Literature DB >> 21397660

S-nitrosylation-regulated GPCR signaling.

Yehia Daaka1.   

Abstract

G protein-coupled receptors (GPCRs) are the most numerous and diverse type of cell surface receptors, accounting for about 1% of the entire human genome and relaying signals from a variety of extracellular stimuli that range from lipid and peptide growth factors to ions and sensory inputs. Activated GPCRs regulate a multitude of target cell functions, including intermediary metabolism, growth and differentiation, and migration and invasion. The GPCRs contain a characteristic 7-transmembrane domain topology and their activation promotes complex formation with a variety of intracellular partner proteins, which form basis for initiation of distinct signaling networks as well as dictate fate of the receptor itself. Both termination of active GPCR signaling and removal from the plasma membrane are controlled by protein post-translational modifications of the receptor itself and its interacting partners. Phosphorylation, acylation and ubiquitination are the most studied post-translational modifications involved in GPCR signal transduction, subcellular trafficking and overall expression. Emerging evidence demonstrates that protein S-nitrosylation, the covalent attachment of a nitric oxide moiety to specified cysteine thiol groups, of GPCRs and/or their associated effectors also participates in the fine-tuning of receptor signaling and expression. This newly appreciated mode of GPCR system modification adds another set of controls to more precisely regulate the many cellular functions elicited by this large group of receptors. This article is part of a Special Issue entitled: Regulation of cellular processes by S-nitrosylation.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21397660      PMCID: PMC3131494          DOI: 10.1016/j.bbagen.2011.03.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  107 in total

1.  S-nitrosylation of beta-arrestin regulates beta-adrenergic receptor trafficking.

Authors:  Kentaro Ozawa; Erin J Whalen; Christopher D Nelson; Yuanyu Mu; Douglas T Hess; Robert J Lefkowitz; Jonathan S Stamler
Journal:  Mol Cell       Date:  2008-08-08       Impact factor: 17.970

2.  Targeting of diacylglycerol degradation to M1 muscarinic receptors by beta-arrestins.

Authors:  Christopher D Nelson; Stephen J Perry; Debra S Regier; Stephen M Prescott; Matthew K Topham; Robert J Lefkowitz
Journal:  Science       Date:  2007-02-02       Impact factor: 47.728

Review 3.  Protein denitrosylation: enzymatic mechanisms and cellular functions.

Authors:  Moran Benhar; Michael T Forrester; Jonathan S Stamler
Journal:  Nat Rev Mol Cell Biol       Date:  2009-09-09       Impact factor: 94.444

4.  Tumour maintenance is mediated by eNOS.

Authors:  Kian-Huat Lim; Brooke B Ancrile; David F Kashatus; Christopher M Counter
Journal:  Nature       Date:  2008-03-16       Impact factor: 49.962

Review 5.  The structure and function of G-protein-coupled receptors.

Authors:  Daniel M Rosenbaum; Søren G F Rasmussen; Brian K Kobilka
Journal:  Nature       Date:  2009-05-21       Impact factor: 49.962

6.  NO production and eNOS phosphorylation induced by epinephrine through the activation of beta-adrenoceptors.

Authors:  Xavier F Figueroa; Inés Poblete; Ricardo Fernández; Cristóbal Pedemonte; Víctor Cortés; J Pablo Huidobro-Toro
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-08       Impact factor: 4.733

7.  S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury.

Authors:  Dong-Hyung Cho; Tomohiro Nakamura; Jianguo Fang; Piotr Cieplak; Adam Godzik; Zezong Gu; Stuart A Lipton
Journal:  Science       Date:  2009-04-03       Impact factor: 47.728

8.  Beta-arrestin-dependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2.

Authors:  Sudha K Shenoy; Aalok S Modi; Arun K Shukla; Kunhong Xiao; Magali Berthouze; Seungkirl Ahn; Keith D Wilkinson; William E Miller; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-10       Impact factor: 11.205

Review 9.  Protein S-nitrosylation in health and disease: a current perspective.

Authors:  Matthew W Foster; Douglas T Hess; Jonathan S Stamler
Journal:  Trends Mol Med       Date:  2009-08-31       Impact factor: 11.951

Review 10.  Location, location, location...site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling.

Authors:  Andrew B Tobin; Adrian J Butcher; Kok Choi Kong
Journal:  Trends Pharmacol Sci       Date:  2008-07-06       Impact factor: 14.819

View more
  11 in total

1.  S-nitrosoglutathione inhibits cerebrovascular angiotensin II-dependent and -independent AT1 receptor responses: A possible role of S-nitrosation.

Authors:  Marie-Lynda Bouressam; Sandra Lecat; Alexandre Raoul; Caroline Gaucher; Caroline Perrin-Sarrado; Isabelle Lartaud; François Dupuis
Journal:  Br J Pharmacol       Date:  2019-05-07       Impact factor: 8.739

2.  The Arf GAP AGAP2 interacts with β-arrestin2 and regulates β2-adrenergic receptor recycling and ERK activation.

Authors:  Yuanjun Wu; Yu Zhao; Xiaojie Ma; Yunjuan Zhu; Jaimin Patel; Zhongzhen Nie
Journal:  Biochem J       Date:  2013-06-15       Impact factor: 3.857

3.  Estradiol Rapidly Attenuates ORL-1 Receptor-Mediated Inhibition of Proopiomelanocortin Neurons via Gq-Coupled, Membrane-Initiated Signaling.

Authors:  Kristie Conde; Cecilia Meza; Martin J Kelly; Kevin Sinchak; Edward J Wagner
Journal:  Neuroendocrinology       Date:  2016-01-16       Impact factor: 4.914

Review 4.  Can nitric oxide-based therapy prevent bronchopulmonary dysplasia?

Authors:  Thomas M Raffay; Richard J Martin; James D Reynolds
Journal:  Clin Perinatol       Date:  2012-09       Impact factor: 3.430

Review 5.  Aging-Induced Impairment of Vascular Function: Mitochondrial Redox Contributions and Physiological/Clinical Implications.

Authors:  Evan Paul Tracy; William Hughes; Jason E Beare; Gabrielle Rowe; Andreas Beyer; Amanda Jo LeBlanc
Journal:  Antioxid Redox Signal       Date:  2021-09-17       Impact factor: 7.468

Review 6.  Targeting G protein coupled receptor-related pathways as emerging molecular therapies.

Authors:  Abdelaziz Ghanemi
Journal:  Saudi Pharm J       Date:  2013-08-13       Impact factor: 4.330

7.  An ancient role for nitric oxide in regulating the animal pelagobenthic life cycle: evidence from a marine sponge.

Authors:  Nobuo Ueda; Gemma S Richards; Bernard M Degnan; Alexandrea Kranz; Maja Adamska; Roger P Croll; Sandie M Degnan
Journal:  Sci Rep       Date:  2016-11-22       Impact factor: 4.379

Review 8.  G-Protein Coupled Receptor Targeting on Myeloid Cells in Atherosclerosis.

Authors:  Emiel P C van der Vorst; Linsey J F Peters; Madeleine Müller; Selin Gencer; Yi Yan; Christian Weber; Yvonne Döring
Journal:  Front Pharmacol       Date:  2019-05-22       Impact factor: 5.810

9.  Identification of GPCR-interacting cytosolic proteins using HDL particles and mass spectrometry-based proteomic approach.

Authors:  Ka Young Chung; Peter W Day; Gisselle Vélez-Ruiz; Roger K Sunahara; Brian K Kobilka
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

10.  Neuroprotective Effects of Inhibiting Fyn S-Nitrosylation on Cerebral Ischemia/Reperfusion-Induced Damage to CA1 Hippocampal Neurons.

Authors:  Lingyun Hao; Xuewen Wei; Peng Guo; Guangyi Zhang; Suhua Qi
Journal:  Int J Mol Sci       Date:  2016-07-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.